Aurobindo Pharma News

• 

  This Firm With Liquor Policy Case Link Bought Rs 52 Crore Electoral Bonds

  Aurobindo Pharma, in total, bought electoral bonds worth ₹52 crore, more than half of which was given to the ruling Bharatiya Janata Party (BJP).

• 

  Aurobindo Pharma Stock Falls Nearly 7% In Early Trade, Hits 52-Week Low After Q2 Results

  Shares of Aurobindo Pharma on Monday fell nearly 7 per cent in early trade after the company reported a 41 per cent decline in its consolidated net profit for the second quarter ended September 30, 2022.

• 

  Aurobindo Pharma's Second Quarter Net Profit Falls 41% To Rs 409 Crore

  Aurobindo Pharma has posted a decline of 41 per cent in its net profit to Rs 409 crore in the quarter ended September against Rs 697 crore in the year-ago period.

• 

  Aurobindo Pharma Shares Gain 3%, A Day After Hitting A 52-Week Low

  Shares of Aurobindo Pharma rose nearly 3 per cent in early trade on Friday, a day after touching a 52-week low.

• 

  Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses

  Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.

• 

  Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market

  Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.

• 

  Stocks To Watch: Nazara Tech, Wipro, Aurobindo Pharma, Cipla

  The domestic stock indices are likely to trade lower on Monday, taking cues from the global markets.

• 

  Stocks To Watch: Tata Steel, Hero MotoCorp, Ashok Leyland, Aurobindo Pharma

  Tata Steel reported a net profit of Rs 9,768 crore in the June quarter compared to a net loss of Rs 4,648 crore in the corresponding quarter last year

• 

  Stocks To Watch: TCS, Aurobindo Pharma, Titan

  Aurobindo Pharma reported an over four-fold jump in consolidated net profit to Rs 2,946.32 crore for the quarter ended December 2020, mainly on account of exceptional gains

• 

  Aurobindo Pharma To Make And Sell COVAXX's Covid-19 Vaccine for India, UNICEF

  Covid-19 vaccine: The Indian drugmaker has non-exclusive rights to sell the shot, which is currently undergoing an early-stage trial, in several emerging markets

• 

  Sebi Slaps Rs 23 Crore Penalty On Aurobindo Pharma Promoters; Shares Fall

  Aurobindo Share Price: Sebi's penalty is for alleged insider trading violations done by Aurobindo Pharma's promoters between 2008 and 2009 when it entered into agreement with Pfizer.

• 

  Lawsuit Against Aurobindo Pharma, Other Drug Makers Filed In US

  Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results.

• 

  Sensex Surges 286 Points, Nifty Settles Above 10,200; Auto, Pharma Stocks Lead Gains

  The BSE Sensex started the first trading session of the new financial year on a positive note. The BSE benchmark index Sensex rose 286 points to close at 33,255, while the NSE Nifty settled 98 points higher at 10,211. Gains were led by buying witnessed across auto and pharma stocks, with the NSE's sectoral indices finishing the day 2-3 per cent hig...

• 

  Aurobindo Pharma To Buy Portugal's Generis For Around Rs 969 Crore

  The company has inked a binding agreement through its wholly-owned subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica for a total consideration of 135 million euros, Aurobindo Pharma said in a statement.

• 

  Aurobindo Pharma Gains On Buzz Of Big UK Acquisition

  Aurobindo Pharma shares gained over 1 per cent on Monday after a news report said that the Indian pharma company is a frontrunner to buy Teva Pharmaceutical's UK business, which had revenue of around $300 million last fiscal.